Omicron-adapted COVID vaccines may reduce death, hospitalization risk - CIDRAP

Omicron-adapted COVID vaccines may reduce death, hospitalization risk  CIDRAP

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and patho...

A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity  Nature

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study  The Lancet

Understanding the COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread and Protection - Stony Brook...

Understanding the COVID-19 Cicada Variant (BA.3.2): Symptoms, Spread and Protection  Stony Brook Medicine

Delta and Omicron Variants Partially Evaded COVID-19 Vaccines, Study Indicates - University of Miami

Delta and Omicron Variants Partially Evaded COVID-19 Vaccines, Study Indicates  University of Miami

What to Know About the New ‘Cicada’ COVID-19 Variant - AARP

What to Know About the New ‘Cicada’ COVID-19 Variant  AARP

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2...

Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021 | MMWR  Centers for Disease Control and Prevention | CDC (.gov)

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant - The New England Jo...

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant  The New England Journal of Medicine

Where did ‘weird’ Omicron come from? - Science | AAAS

Where did ‘weird’ Omicron come from?  Science | AAAS

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants - Yale Medicine

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants  Yale Medicine

COVID-19 vaccines induce immune response to Omicron - National Institutes of Health (.gov)

COVID-19 vaccines induce immune response to Omicron  National Institutes of Health (.gov)

Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses...

Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort  Nature

Statement on Omicron sublineage BA.2 - World Health Organization (WHO)

Statement on Omicron sublineage BA.2  World Health Organization (WHO)

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 - Centers for Disease ...

SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021  Centers for Disease Control and Prevention | CDC (.gov)

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa - The New England Journ...

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa  The New England Journal of Medicine

Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa - Nature

Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa  Nature

Update on Omicron - World Health Organization (WHO)

Update on Omicron  World Health Organization (WHO)

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 - The New England Journal of Medicine

A Bivalent Omicron-Containing Booster Vaccine against Covid-19  The New England Journal of Medicine

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies  Nature

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections - The New England...

Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections  The New England Journal of Medicine

Omicron has caused higher increase in U.S. daily death count than delta variant - PBS

Omicron has caused higher increase in U.S. daily death count than delta variant  PBS

One year since the emergence of COVID-19 virus variant Omicron - World Health Organization (WHO)

One year since the emergence of COVID-19 virus variant Omicron  World Health Organization (WHO)

The latest on COVID-19’s omicron variant: What’s changed? - UT MD Anderson

The latest on COVID-19’s omicron variant: What’s changed?  UT MD Anderson

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)

TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization (WHO)

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge - The New England Journal ...

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge  The New England Journal of Medicine

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  The New England Journal of Medicine

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel - The New England Journal of Me...

Protection by a Fourth Dose of BNT162b2 against Omicron in Israel  The New England Journal of Medicine

New evidence shows omicron likely spreads twice as fast as delta in South Africa - NPR

New evidence shows omicron likely spreads twice as fast as delta in South Africa  NPR

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection - The New England Journ...

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection  The New England Journal of Medicine

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization - Nature

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization  Nature

Paxlovid reduces serious risks from Omicron variants - National Institutes of Health (.gov)

Paxlovid reduces serious risks from Omicron variants  National Institutes of Health (.gov)

How effective are COVID-19 vaccines against omicron? - PBS

How effective are COVID-19 vaccines against omicron?  PBS

COVID-19’s BA.4 and BA.5 Omicron subvariants: 12 questions, answered - UT MD Anderson

COVID-19’s BA.4 and BA.5 Omicron subvariants: 12 questions, answered  UT MD Anderson

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection - The New England Journal...

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection  The New England Journal of Medicine

Where did Omicron come from? Three key theories - Nature

Where did Omicron come from? Three key theories  Nature

Plasma Neutralization of the SARS-CoV-2 Omicron Variant - The New England Journal of Medicine

Plasma Neutralization of the SARS-CoV-2 Omicron Variant  The New England Journal of Medicine

Omicron: What We Know About the Dominant Coronavirus Variant - The New York Times

Omicron: What We Know About the Dominant Coronavirus Variant  The New York Times

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa ...

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa  The New England Journal of Medicine

The Omicron Booster: Your Questions Answered - Yale Medicine

The Omicron Booster: Your Questions Answered  Yale Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants  The New England Journal of Medicine

An Update on Omicron Subvariants - Johns Hopkins Bloomberg School of Public Health

An Update on Omicron Subvariants  Johns Hopkins Bloomberg School of Public Health

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 - Nature

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5  Nature

BNT162b2 Protection against the Omicron Variant in Children and Adolescents - The New England Jou...

BNT162b2 Protection against the Omicron Variant in Children and Adolescents  The New England Journal of Medicine

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 - The New England Journal of ...

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75  The New England Journal of Medicine

‘Killer’ immune cells still recognize Omicron variant - Nature

‘Killer’ immune cells still recognize Omicron variant  Nature

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron - The New England Journal of M...

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron  The New England Journal of Medicine

Effectiveness of Bivalent Boosters against Severe Omicron Infection - The New England Journal of ...

Effectiveness of Bivalent Boosters against Severe Omicron Infection  The New England Journal of Medicine

What Mayo experts know about the omicron variant - Mayo Clinic News Network

What Mayo experts know about the omicron variant  Mayo Clinic News Network

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination - The New England J...

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination  The New England Journal of Medicine

Omicron Variant: “A Little Too Much Hype, Saying This Is the Next Scary Thing” - Boston University

Omicron Variant: “A Little Too Much Hype, Saying This Is the Next Scary Thing”  Boston University

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time - National Institutes of...

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time  National Institutes of Health (.gov)

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature

Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron  Nature

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation - Nature

Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation  Nature

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar - The New England J...

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar  The New England Journal of Medicine

Omicron: increased transmissibility and decreased pathogenicity - Nature

Omicron: increased transmissibility and decreased pathogenicity  Nature

“Stealth Omicron”: Everything you need to know about the new BA.2 subvariant of SARS-CoV-2 - Gavi...

“Stealth Omicron”: Everything you need to know about the new BA.2 subvariant of SARS-CoV-2  Gavi, the Vaccine Alliance

Durability of Bivalent Boosters against Omicron Subvariants - The New England Journal of Medicine

Durability of Bivalent Boosters against Omicron Subvariants  The New England Journal of Medicine

CDC recommends new booster shots to fight omicron - NPR

CDC recommends new booster shots to fight omicron  NPR

Protection against Omicron from Vaccination and Previous Infection in a Prison System - The New E...

Protection against Omicron from Vaccination and Previous Infection in a Prison System  The New England Journal of Medicine

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex ...

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex  Science | AAAS

Modeling transmission of SARS-CoV-2 Omicron in China - Nature

Modeling transmission of SARS-CoV-2 Omicron in China  Nature

Effects of Vaccination and Previous Infection on Omicron Infections in Children - The New England...

Effects of Vaccination and Previous Infection on Omicron Infections in Children  The New England Journal of Medicine

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 - The Lancet

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2  The Lancet

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants - The New England Journ...

Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants  The New England Journal of Medicine

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants ...

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants  The New England Journal of Medicine

Omicron: 10 things to know about the very contagious COVID-19 variant - University of California ...

Omicron: 10 things to know about the very contagious COVID-19 variant  University of California - Davis Health

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age - The New England...

BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age  The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 - The New Engla...

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5  The New England Journal of Medicine

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - The New England Journal...

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB  The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6 - The New England Journal of Medicine

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6  The New England Journal of Medicine

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates - Nature

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates  Nature

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection - The New England...

Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection  The New England Journal of Medicine

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection - The New England Journ...

Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection  The New England Journal of Medicine

How Ominous Is the Omicron Variant (B.1.1.529)? - American Society for Microbiology

How Ominous Is the Omicron Variant (B.1.1.529)?  American Society for Microbiology

Beyond Omicron - Harvard Medical School

Beyond Omicron  Harvard Medical School

Omicron thwarts some of the world’s most-used COVID vaccines - Nature

Omicron thwarts some of the world’s most-used COVID vaccines  Nature

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection - The New England Journal ...

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection  The New England Journal of Medicine

Omicron is now the dominant COVID strain in the U.S., making up 73% of new infections - NPR

Omicron is now the dominant COVID strain in the U.S., making up 73% of new infections  NPR

Omicron’s lasting mysteries: four questions scientists are racing to answer - Nature

Omicron’s lasting mysteries: four questions scientists are racing to answer  Nature

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron - Nature

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron  Nature

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters - Nature

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters  Nature

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...

What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant - Nature

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant  Nature

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo - Nature

SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo  Nature

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy - Nature

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy  Nature

How does Omicron spread so fast? A high viral load isn’t the answer - Nature

How does Omicron spread so fast? A high viral load isn’t the answer  Nature

If Omicron is less severe, why are COVID-19 deaths rising? - The World Economic Forum

If Omicron is less severe, why are COVID-19 deaths rising?  The World Economic Forum

T cell responses to SARS-CoV-2 spike cross-recognize Omicron - Nature

T cell responses to SARS-CoV-2 spike cross-recognize Omicron  Nature

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting - Nature

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting  Nature

Cardiologic Manifestations in Omicron‐Type Versus Wild‐Type COVID ‐19: A Systematic Echocardiogra...

Cardiologic Manifestations in Omicron‐Type Versus Wild‐Type COVID ‐19: A Systematic Echocardiographic Study  American Heart Association Journals

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants - Nature

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants  Nature

Omicron booster shots are coming—with lots of questions - Science | AAAS

Omicron booster shots are coming—with lots of questions  Science | AAAS

Children are eligible for Omicron boosters, too! | Department of Public Health - City of Philadel...

Children are eligible for Omicron boosters, too! | Department of Public Health  City of Philadelphia (.gov)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections - Nature

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections  Nature

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal...

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue  Nature

Omicron Q&A: Making Some Sense of the Messiness of This Moment - Johns Hopkins Bloomberg School o...

Omicron Q&A: Making Some Sense of the Messiness of This Moment  Johns Hopkins Bloomberg School of Public Health

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron - The New England ...

Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron  The New England Journal of Medicine

COVID reinfections surge during Omicron onslaught - Nature

COVID reinfections surge during Omicron onslaught  Nature